Menu

Image of the Day: That Toad Is Poison

The introduction of the poisonous Duttaphrynus melanostictus into Madagascar could be fatally risky for the island’s native predators.

Jun 5, 2018
Sukanya Charuchandra

Asian toad (Duttaphrynus melanostictus)DUTTAPHRYNUS_MELANOSTICTUS_ASIAN_TOAD_PHOTO_WOLFGANG_WUSTERA genetic study published yesterday (June 4) in Current Biology reaffirms earlier fears of conservation biologists that the entry of the Asian toad (Duttaphrynus melanostictus) into Madagascar could be disastrous for the island’s native wildlife. The toad’s poison obstructs the function of a sodium-potassium pump needed for proper functioning of the cell membrane. Resistance to this toxin by animals that eat the toad is reflected in the form of a mutated genetic sequence for this pump. When researchers sequenced this region of the genome for 77 island species, they found only one rodent exhibited a possible resistance to the Asian toad.

Wolfgang Wüster, a coauthor on the paper, cautions in a statement, “predators that frequently feed on toads and do not rapidly learn or evolve to avoid them are likely to become much rarer or possibly extinct.” His results reinforce the need for urgent implementation of a plan to control the spread of this species.

B.M. Marshall et al., “Widespread vulnerability of Malagasy predators to the toxins of an introduced toad,” Curr Biol, doi:10.1016/j.cub.2018.04.024, 2018.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!